Kubota Pharmaceutical Holdings Co.,Ltd. [4596.T]
TOKYO, Apr 24 (Pulse News Wire) – Kubota Pharmaceutical Holdings CO.,LTD. (4596.T) announced today that its board of directors resolved to issue restricted shares as part of a share-based compensation program.
The issuance, scheduled for May 8, 2026, involves issuing ordinary shares worth up to ¥167.0 million to one executive director as part of a performance incentive plan aimed at enhancing motivation and aligning interests with shareholders. Under the program, the newly issued shares will be subject to restrictions until the executive loses their position as a director, officer, or employee of the company. The shares will also be managed in a dedicated account at a securities firm designated by the company during the restriction period.
The issuance price per share is set at ¥96, based on the closing price of the company's stock on the Tokyo Stock Exchange on April 23, 2026. Additionally, the company noted that the total monetary compensation bonds being converted into shares amount to ¥167.0 million. The number of ordinary shares to be issued is 1,740,000, and the total value of the issuance is __NUM_2__.
The company received approval from its annual general meeting held, to implement this scheme within the stipulated limits.
🟡 Confidence: Standard AI-translated content.